我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。
开放获取期刊获得更多读者和引用 700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
特刊文章
Biosimilars: Global Acceptance, Importance of Regulatory Consistency and current trends
Translational Oncology Research and its Clinical impact using pioneering examples
Packaging Challenge for Affordable Biosimilar Products
Role of Women in the Study of Analgesic activity of Holarrhena antidysenterica leaves extract
Biomanufacturing Programmes for Early Phase mAb Development
Regulatory Progress of Biosimilars: An Update
in vitro screening of cytotoxic activities of hopea ponga (dennst.) Bark extracts
In Vivo Anti-Inflammatory Activity Of Pajanelia Longifoliabark Extracts
Virtual Behavioural Health Integration into Primary Care – A Clinical Trial
Illegal Trafficking of Banned Drugs of Having Adverse Effect on Human Health.
The Connective Tissue Manipulation as Prevention to Avoid Anti-inflammatories in Musculoskeletal Pain
Financial and Economic Criteria for Evaluating the Performance of Pharmacies
Copyright in Gene Sequences
A Comprehensive and Multidisciplinary Methodology to Improve Biosimilar Uptake in the United States
Comparative Study of Pharmacokinetics and Safety of RPH-001 and Avastin after Single Dose 5mg/kg Given Intravenously to Healthy Male Volunteers
Cage Match: Inter Partes Review and Post Grant Review vs. Biologics and Biosimilars
Biosimilars Interchangeability in the USA: The Final US-FDA Guidance to Industry
Biosimilars Summit & Clinical Trails 2020_Past conference Report
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi